SCHEMBL23928703

SCHEMBL23928703

C=CC(=O)c1ccc(-c2nn(-c3ccccc3)cc2C(=O)O)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
L3MBTL1 Q9Y468 4/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
HPGD P15428 2/20 0.64
KDM4E B2RXH2 2/20 0.64
HSD17B10 Q99714 1/20 0.64
ATM Q13315 1/20 0.62
MEN1 O00255 8/20 0.55
KMT2A Q03164 8/20 0.55
MAPT P10636 5/20 0.54
RAB9A P51151 2/20 0.53
POLB P06746 2/20 0.53
HTT P42858 1/20 0.53
LMNA P02545 1/20 0.52
AURKA O14965 4/20 0.51
TP53 P04637 1/20 0.51
CA12 O43570 1/20 0.51
CA9 Q16790 1/20 0.51
USP2 O75604 1/20 0.49
RECQL P46063 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22095108 0.84 PTGS2 (0.68) ALDH1A1SMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL28771391 0.83 ALDH1A1 (0.78) ALDH1A1L3MBTL1SMN1; SMN2HPGDKDM4E
SCHEMBL4501557 0.83 ALDH1A1 (0.82) ALDH1A1L3MBTL1SMN1; SMN2HPGDKDM4E
SCHEMBL4502915 0.81 ALDH1A1 (0.74) ALDH1A1L3MBTL1SMN1; SMN2HPGDKDM4E
SCHEMBL4257667 0.80 ALDH1A1 (0.72) ALDH1A1L3MBTL1SMN1; SMN2HPGDKDM4E
SCHEMBL14132424 0.80 L3MBTL1 (0.72) ALDH1A1L3MBTL1SMN1; SMN2HPGDKDM4E
SCHEMBL23928603 0.80 ALDH1A1 (0.72) ALDH1A1L3MBTL1SMN1; SMN2HPGDKDM4E
SCHEMBL6683128 0.80 L3MBTL1 (0.73) ALDH1A1L3MBTL1SMN1; SMN2HPGDKDM4E
SCHEMBL23928672 0.80 ALDH1A1 (0.64) ALDH1A1L3MBTL1SMN1; SMN2HPGDKDM4E
SCHEMBL23928522 0.80 MAPT (0.74) ALDH1A1L3MBTL1SMN1; SMN2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548875-B2 Inhibitor compounds for male contraception UNIVERSITY OF WASHINGTON (US) 2023-01-10 US disclosed
US-20210332030-A1 INHIBITOR COMPOUNDS FOR MALE CONTRACEPTION UNIVERSITY OF WASHINGTON (US) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332030-A1 INHIBITOR COMPOUNDS FOR MALE CONTRACEPTION ALDH1A1, ALDH3A1, ALDH16A1 ALDH1A1 1/4885L3MBTL1 4048/4885SMN1; SMN2 2873/4885
US-11548875-B2 Inhibitor compounds for male contraception ALDH1A1, ALDH3A1, ALDH16A1 ALDH1A1 1/4885L3MBTL1 4048/4885SMN1; SMN2 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.